Ditchcarbon
  • Contact
  1. Organizations
  2. DBV Technologies S.A.
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 13 days ago

DBV Technologies S.A.

Company website

DBV Technologies S.A., a pioneering biopharmaceutical company headquartered in France, focuses on developing innovative treatments for food allergies and other immune-mediated diseases. Founded in 2002, the company has made significant strides in the field of immunotherapy, particularly with its proprietary Viaskin® technology, which offers a unique, non-invasive method for delivering therapeutic proteins through the skin. With a strong presence in Europe and North America, DBV Technologies is recognised for its commitment to advancing patient care through its core product offerings, including the Viaskin Peanut patch, designed to desensitise individuals with peanut allergies. The company has achieved notable milestones, including successful clinical trials and partnerships that enhance its market position in the biopharmaceutical industry. As a leader in allergy treatment innovation, DBV Technologies continues to shape the future of immunotherapy.

DitchCarbon Score

How does DBV Technologies S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

28

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

DBV Technologies S.A.'s score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

49%

Let us know if this data was useful to you

DBV Technologies S.A.'s reported carbon emissions

DBV Technologies S.A., headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. As a result, there is no available information on their Scope 1, 2, or 3 emissions or any significant achievements in carbon reduction. The company appears to be in the early stages of establishing its climate commitments, which is not uncommon in the biotechnology sector. Without specific emissions data or targets, it is challenging to assess DBV Technologies S.A.'s overall climate impact or commitments. The company may benefit from developing a structured approach to measuring and reporting its carbon footprint in alignment with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DBV Technologies S.A.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DBV Technologies S.A. is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DBV Technologies S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 22 hours ago

Genmab

DK
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Vectura

GB
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

NIOX Group Plc

GB
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Ablynx NV

BE
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Alk

DK
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy